{
    "eid": "2-s2.0-85015593202",
    "title": "Role of rilpivirine and etravirine in efavirenz and nevirapine-based regimens failure in a resource-limited country: A cross- Sectional study",
    "cover-date": "2016-04-01",
    "subject-areas": [
        {
            "$": "Multidisciplinary",
            "@code": "1000"
        }
    ],
    "keywords": [],
    "authors": [
        "Phairote Teeranaipong"
    ],
    "citedby-count": 15,
    "ref-count": 24,
    "ref-list": [
        "Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents",
        "Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand",
        "Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for A Public Health Approach",
        "Rilpivirine: A step forward in tailored HIV treatment",
        "Rilpivirine: A second-generation nonnucleoside reverse transcriptase inhibitor",
        "Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): A phase 3, randomised, non-inferiority trial",
        "Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): A phase 3 randomised double-blind active-controlled trial",
        "The role of rilpivirine in clinical practice: Strengths and weaknesses of the new nonnucleoside reverse transcriptase inhibitor for HIV therapy",
        "Genotypic and phenotypic characterization of HIV-1 isolates obtained from patients on rilpivirine therapy experiencing virologic failure in the phase 3 ECHO and THRIVE studies: 48-week analysis",
        "Rilpivirine: A new non-nucleoside reverse transcriptase inhibitor",
        "Characterization of HIV-1 drug resistance development through week 48 in antiretroviral naive subjects on rilpivirine/emtricitabine/tenofovir DF or efavirenz/emtricitabine/tenofovir DF in the STaR study (GS-US-264-0110)",
        "Efficacy and safety of etravirine at week 96 in treatment-experienced HIV type-1-infected patients in the DUET-1 and DUET-2 trials",
        "Characterization of genotypic and phenotypic changes in HIV-1-infected patients with virologic failure on an etravirine-containing regimen in the DUET-1 and DUET-2 clinical studies",
        "WHO HIV Drug Resistance Report 2012",
        "Five-year outcomes of the China National Free Antiretroviral Treatment Program",
        "Etravirine and rilpivirine resistance in HIV-1 subtype CRF01-AE-infected adults failing non-nucleoside reverse transcriptase inhibitor-based regimens",
        "The HIVdb system for HIV-1 genotypic resistance interpretation",
        "Initiation of antiretroviral therapy in early asymptomatic HIV infection",
        "Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails",
        "Resistance profile of etravirine: Combined analysis of baseline genotypic and phenotypic data from the randomized, controlled Phase III clinical studies",
        "Distribution of human immunodeficiency virus type 1 protease and reverse transcriptase mutation patterns in 4,183 persons undergoing genotypic resistance testing",
        "Short communication prevalence of susceptibility to etravirine by genotype and phenotype in samples received for routine HIV type 1 resistance testing in the United States",
        "Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies",
        "Evaluating the role of Etravirine in the second-line antiretrovinal therapy after failing an initial non-nucleoside reverse transcriptase inhibitor-based regimen in a resource-limited setting"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Thai Red Cross Agency",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Thai Red Cross AIDS Research Centre",
        "National Science and Technology Development Agency",
        "Thailand Research Fund",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}